Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

PURPOSE: Preclinical models suggest that the use of anti–vascular endothelial growth factor (anti-VEGF) therapy with antiestrogens may prevent or delay the development of endocrine therapy resistance. We therefore performed a feasibility study to evaluate the safety of letrozole plus bevacizumab in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Traina, Tiffany A., Rugo, Hope S., Caravelli, James F., Patil, Sujata, Yeh, Benjamin, Melisko, Michele E., Park, John W., Geneus, Stephanie, Paulson, Matthew, Grothusen, Jill, Seidman, Andrew D., Fornier, Monica, Lake, Diana, Dang, Chau, Robson, Mark, Theodoulou, Maria, Flombaum, Carlos D., Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2010
Schlagworte:
ORIGINAL REPORTS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3940895/
https://ncbi.nlm.nih.gov/pubmed/19841327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8784
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge